NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/05/2025
Back to search
Official data from USPTO
SEFACOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
09/06/2025
Trademark type
Word
Nice classes
42
Filing date
08/24/2017
Registration date
03/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2025
Last transaction
09/06/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
04/28/2004
First use in commerce
04/28/2006
Drawing code
4
Owner type
03
Owner location
Somerville, MA
Examiner
KOVALSKY, LAURA
Current location
Historical data usage
Holders and representatives
Holders
SEFACOR INC.
Representatives
SEFACOR INC.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research in the field of natural resources; Research on the subject of pharmaceuticals; Analysis for oil research; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific researchconducting clinical trials for others; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research services; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
15 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/05/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/05/2025
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
04/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2025
ES8R
TEAS SECTION 8 RECEIVED
09/23/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2018
PUBO
PUBLISHED FOR OPPOSITION
01/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2017
DOCK
ASSIGNED TO EXAMINER
11/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2017
NWAP
NEW APPLICATION ENTERED
08/28/2017
Continuous trademark protection
Get notified about every new filing that threatens SEFACOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.